Immuto Scientific

Immuto Scientific is a biotech platform company pioneering a new era in therapeutic discovery by targeting the once thought 'undruggable' proteins and pathways, bringing hope to millions of patients facing conditions with no cure. Its innovative platform combines cutting-edge technology with deep scientific expertise to unlock novel therapies that traditional methods couldn't reach. The heart of the company's approach is a powerful structure-based drug discovery engine that enables high throughput characterization of protein structures in live cells. Its platform is universally compatible and works on complex membrane protein drug targets, such as GPCRs and ion channels that are not compatible with current analytical techniques or for which no structural information exists.